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Introduction
Snail1, a zinc-finger transcriptional repressor, plays an impor-
tant role in the epithelial–mesenchymal transition (EMT) and 
complementary morphogenetic programs that control normal 
development,  but  its  inappropriate  expression  in  cancer  has 
been linked to disease progression (Moody et al., 2005; Peinado 
et al., 2007; Debies et al., 2008; Kudo-Saito et al., 2009; Thiery 
et al., 2009; Vincent et al., 2009; Wu et al., 2009; Mak et al., 
2010). By co-opting developmental processes, neoplastic cells 
mobilize Snail1 to promote EMT-like programs and the associ-
ated tissue-invasive phenotype characteristic of aggressive can-
cers (Ota et al., 2009; Polyak and Weinberg, 2009). Associations 
between increased Snail1 expression and cancer progression raise 
the possibility that oncogenic events promote Snail-dependent 
EMT programs by as yet uncharacterized mechanisms (Peinado 
et al., 2007; Polyak and Weinberg, 2009). In this regard, the tumor 
suppressor, p53, is mutated in >50% of human cancers, wherein 
loss of function is associated with a more aggressive disease 
phenotype, raising the possibility that functional links may   
exist between p53 and Snail1 activity (Gunther et al., 2003; 
Chen et al., 2007; Gadea et al., 2007; He et al., 2007b; Debies   
et al., 2008; Godar et al., 2008; Morton et al., 2008; Riley   
et al., 2008).
Herein, we demonstrate that p53 loss of function or muta-
tion promotes EMT-like programs in human cancer cells by de-
repressing Snail1 protein expression and activity. In the absence 
of wild-type (wt) p53, Snail1 activity is up-regulated as a con-
sequence of a decrease in miRNA-34 (miR-34) levels, which 
normally serve to antagonize Snail1 expression by binding to 
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DNA-contact mutant (e.g., R273H; Brosh and Rotter, 2009), 
whereby Snail1 protein expression is induced along with de-
creases in E-cadherin staining (Fig. 3, A and B). Though p53 
mutants have been reported to increase Slug/Snail2 protein 
levels (Wang et al., 2009), no changes in its expression are 
observed under these conditions (Fig. 3 C). Of note, the ability 
of p53 to regulate Snail1 is not restricted to cells of epithe-
lial origin alone, as p53 wt fibroblasts harboring floxed p53   
alleles up-regulate Snail1 after Cre-mediated excision, whereas 
p53
/  fibroblasts  down-regulate  Snail1  protein  expression 
when wt p53 expression is restored (Fig. 3 D).
p53 regulates Snail1 by modulating  
miR-34 expression
Though p53 does not directly regulate Snail1 mRNA expression   
(Fig. S1), bioinformatic analysis of the 3 Snail1 UTR (Lee et al., 
2009) identified two potential targeting sites for the p53-regulated   
microRNAs  miR-34a,  miR-34b,  and  miR-34c  (Fig.  4  A;   
Bommer et al., 2007; Chang et al., 2007; Corney et al., 2007; 
He et al., 2007a; Raver-Shapira et al., 2007; Tarasov et al., 
2007). Importantly, both the Snail1-binding domains in miR-34 
family members as well as the miR-34–binding domains in the 
3 UTR of Snail1 orthologues are highly conserved (Table S1).   
To  determine  whether  miR-34  family  members  are  able  to 
directly inhibit Snail1 expression, the 3 UTR of Snail1 was 
cloned downstream of a luciferase reporter construct and its 
expression monitored in the absence or presence of miR-34a, 
miR-34b, or miR-34c. Reporter expression is suppressed signif-
icantly by each of the miR-34 species in either A549 or MCF-7 
cell lines, whereas reporter activity increases when p53 levels   
are suppressed (Fig. 4 B and Fig. S2). Furthermore, miR-34–
dependent repression of the Snail1 3 UTR reporter is ablated after   
mutation of the predicted microRNA targeting sequences (Fig. 4 C).   
Each of the miRNAs also inhibited Snail1 protein expression 
when cells were transfected with a Snail1 expression vector 
harboring the 3 UTR of the endogenous transcript (Fig. 4 D).   
Likewise, knockdown of endogenous miR-34a levels only   
increases Snail1 protein levels when the expression vector in-
cludes the 3 UTR (Fig. 4 D). Consistent with the demonstrated 
ability of p53 to regulate miR-34 (Bommer et al., 2007; Chang 
et al., 2007; Corney et al., 2007; He et al., 2007a; Raver-Shapira   
et al., 2007; Tarasov et al., 2007), miR-34a and miR-34c ex-
pression increase as a function of wt p53 levels in A549 or 
MCF-7 cells as well as fibroblasts (Fig. S2; miR-34b is not de-
tected under these conditions). In turn, when miR-34a expres-
sion (the dominant miR-34 family member detected in A549 
or MCF-7 cell lines; unpublished data) is silenced, repression 
of the Snail1 3 UTR reporter is relieved and the accumulation 
of endogenous Snail1 protein is enhanced in association with 
the suppression of E-cadherin protein levels, claudin-3 and oc-
cludin mRNA levels, as well as the induction of fibronectin and 
vimentin mRNA levels (Fig. 4 E and Fig. S3). Conversely, al-
though low levels of Snail1 can be detected in A549 or MCF-7 
cells (Fig. 5 A), further decreases in endogenous Snail1 protein 
content and 3 UTR reporter activity are observed when p53 
and miR-34a levels are increased in response to the MDM-2 
inhibitor, nutlin-3a (Fig. 5, A–C; Kumamoto et al., 2008).
highly  conserved  3  untranslated  regions  (UTRs)  within  the 
Snail1 transcript itself as well as a series of accessory targets 
that  directly  control  Snail1  protein  half-life  and  activity.   
Together, these data identify a new link between p53, EMT, 
and the activation of Snail1-dependent invasion programs in 
neoplastic states.
Results
p53 controls Snail1 expression
Wt HCT116-p53
+/+ carcinoma cells form confluent monolayers 
and display prominent E-cadherin staining (Fig. 1 A). In con-
trast, an isogenic HCT116 cell line in which both alleles of p53   
are inactivated by homologous recombination (HCT116-p53
/; 
Bunz et al., 1998) expresses only low levels of E-cadherin at 
cell–cell borders (Fig. 1 A). Western blot analyses confirm that 
E-cadherin protein expression is largely ablated in HCT116-
p53
/ cells, whereas transduction of null cells with a p53 ex-
pression vector rescues both E-cadherin staining and protein 
expression (Fig. 1, A and B). Consistent with the possible in-
duction of an EMT program coincident with the loss of p53 
expression, HCT116-p53
/ cells also express lower mRNA 
levels of the epithelial markers claudin-3 and occludin, coupled 
with increased expression of the mesenchymal markers, fibro-
nectin and vimentin (Fig. 1 C). As multiple EMT-inducing tran-
scription factors can repress E-cadherin expression through the 
tandem E-box domains located in its proximal promoter region 
(Peinado et al., 2007), HCT116 p53
+/+ and p53
/ cells were 
transfected with E-cadherin promoter constructs, which contain 
either the wt or mutated domains (Yook et al., 2005). Under 
these conditions, wt E-cadherin promoter activity is repressed 
in HCT116-p53
/ cells via a process that is reversed completely 
after wt p53 transduction (Fig. 1 D). Although Snail1, Snail2, 
Zeb1, and Zeb2 can each mediate E-box–dependent repression 
of E-cadherin expression (Peinado et al., 2007), only Snail1 
mRNA and protein levels are increased in HCT116-p53
/ cells 
by Western blot analysis or nuclear staining (Fig. 1, B and E; and 
Fig. S1). The dominant role of Snail1 in regulating E-cadherin 
is established by the fact that siRNA-mediated Snail1 silencing 
in HCT116-p53
/ cells rescues E-cadherin promoter activity 
(Fig. 1 D). In contrast, knockdown of Slug/Snail2, Zeb1, Zeb2, 
or Twist1 does not affect E-cadherin promoter activity in a p53-
dependent fashion (Fig. S1).
The ability of p53 inactivation to induce Snail1-dependent   
E-cadherin repression is not limited to HCT116 cells, as degra-
dation of wt p53 by the oncogenic HPV-E6 protein (Scheffner 
et al., 1990) or siRNA-mediated knockdown of p53 similarly 
trigger  EMT  programs  in  A549  non-small  lung  carcinoma 
cells as well as MCF-7 breast carcinoma cells (Fig. 2, A–D). 
After p53 suppression in A549 or MCF-7 cells, E-cadherin 
protein expression and reporter activity decrease in tandem 
with (a) the down-regulation of claudin-3 and occludin ex-
pression,  (b)  increases  in  fibronectin  and  vimentin  mRNA 
levels,  and  (c)  the  induction  of  Snail1  protein  expression   
(Fig. 2, A–F; and Fig. S1). Alternatively, similar results are 
observed when MCF-7 cells harboring wt p53 are transfected 
with  either  a  p53  conformational  mutant  (e.g.,  R175H)  or 419 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
and proteasomal destruction (Zhou et al., 2004; Yook et al., 
2005; Yook et al., 2006; Wu et al., 2009; MacPherson et al., 
2010; Mak et al., 2010). Snail1 protein levels are, however, 
stabilized by activating the canonical Wnt signaling cascade 
wherein  induction  of  the  -catenin–LEF-1  transcriptional 
complex leads to the inhibition of GSK3-dependent Snail1 
phosphorylation (Yook et al., 2005, 2006). In this regard, the 
A novel p53/miR-34 axis dictates Snail1 
protein stability and activity
Independent  of  microRNA-dependent  Snail1  translational 
control, Snail1 function is also regulated posttranslationally   
by the Wnt canonical pathway (Yook et al., 2005, 2006). Under 
baseline conditions, Snail1 undergoes rapid GSK3-dependent 
phosphorylation, which initiates its subsequent ubiquitination 
Figure 1.  p53-dependent reciprocal regulation of E-cadherin and Snail1 expression. (A) Laser confocal images of E-cadherin expression in wt HCT116 
(top left) and isogenic p53
/ cells. E-cadherin is reexpressed in p53-null HCT116 cells 7 d after transduction with a wt p53-expressing adenovirus. Bar, 
10 µm. (B) Immunoblot analyses of endogenous Snail1 and E-cadherin protein levels in wt versus p53-null HCT116 cells (left). After adenoviral transduction 
with a control or wt p53 expression vector, endogenous Snail1 and E-cadherin expression levels were determined in p53-null HCT116 cells after a 7-d 
culture period (right). Tubulin is used as the loading control. (C) Claudin-3, occludin, fibronectin, and vimentin expression levels were determined by RT-PCR 
analysis in wt and p53-null HCT-116 cells before or after Snail1 silencing. GAPDH levels were determined as internal control. (D) E-cadherin promoter ac-
tivities of wt (blue) or E-box mutant (red) firefly luciferase constructs were determined in HCT116-p53
+/+ and HCT116-p53
/ cells. Decreases in E-cadherin 
promoter activity of HCT116-p53
/ cells are reversed 7 d after adenoviral transduction with wt p53 (Ad-p53) or 48 h after electroporation with either of 
two independent siRNAs directed against Snail1 (siSnail1 and unpublished data). Activity of the E-cadherin promoter constructs were normalized to the 
activity of a cotransfected SV-40 promoter renilla luciferase construct. Results are expressed as the mean ± 1 SD of three or more experiments (error bars; 
*, P ≤ 0.01). (E) Confocal images of endogenous Snail1 expression in HCT116-p53
+/+ and p53
/ cells. Endogenous Snail1 expression was detected 
with a monoclonal antibody directed against Snail1 in HCT116-p53
+/+ and HCT116-p53
/ cells after adenoviral transduction of the p53-null cells with 
a control (HCT116-p53
//mock) or p53 (HCT116-p53
//Ad-p53) expression vector. Bar, 10 µm.JCB • VOLUME 195 • NUMBER 3 • 2011   420
the p53
+/+ control cells (Fig. 6 C). Further, p53-null cells also 
express higher protein levels of -catenin and LEF-1 (Fig. 6 D). 
After ectopic expression of miR-34a in HCT116-p53
/ cells,   
however, -catenin and LEF-1 protein levels decrease (Fig. 6 D). 
In coincident fashion, when p53
/ HCT116 cells are trans-
fected with epitope-tagged Snail1 (wherein the 3 UTR is de-
leted to monitor effects on Snail1 protein stability alone) in 
tandem with miR-34a, Snail1 protein half-life is reduced by 
more than twofold (Fig. 6 D). Consistent with recent findings 
3 UTRs of -catenin and LEF-1 contain miR-34 binding 
sites that are also sensitive to miR-34a, miR-34b, and miR-34c– 
dependent  regulation  (Fig.  6,  A  and  B;  and  unpublished 
observation). As HCT116 cancer cells harbor an endogenous 
-catenin mutation that results in the constitutive activation   
of the -catenin–LEF-1 pathway (Morin et al., 1997), the impact 
of the p53/miR-34a axis on Snail1 protein stability was exam-
ined. As predicted, 3 UTR reporter activity of -catenin or 
LEF-1 is significantly increased in HCT116-p53
/ relative to 
Figure 2.  E-cadherin and Snail1 expression after HPV-E6–dependent p53 degradation. (A) A549 cells were stably transfected with control (Mock) or 
HPV-E6 expression vectors. Cells were stained with anti–E-cadherin and anti-Snail1 antibodies for confocal imaging. Bar, 10 µm. (B) Endogenous p53, 
E-cadherin, and Snail1 levels were determined by immunoblot analysis in A549 cells transfected with control (Mock) versus HPV-E6 expression vectors, 
cells transfected with control versus p53-specific siRNA. Tubulin is used as the loading control. (C) MCF-7 cells were stably transfected with control (Mock) 
or HPV-E6 expression vectors. Cells were stained with anti–E-cadherin or anti-Snail1 antibodies for confocal imaging. Bar, 10 µm. (D) Endogenous p53, 
E-cadherin, and Snail1 levels were determined in MCF-7 cells as described above in B. (E) E-cadherin promoter activity of wt (blue) or E-box mutant (red) 
firefly luciferase constructs was determined in mock- or HPV-E6–transfected cells. Activity of the E-cadherin promoter construct was normalized to the activity 
of a cotransfected SV-40 promoter renilla luciferase complex. Results are expressed as the mean ± 1 SD (error bars; n = 3, *, P ≤ 0.01). (F) Claudin-3, 
occludin, fibronectin, and vimentin expression levels were determined by RT-PCR analysis in mock- or HPV-E6–transfected A549 as well as MCF-7 cells.421 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
protein levels, not only by allowing for increased Snail1 trans-
lation, but also by increasing Snail1 protein stability via the 
regulation of canonical Wnt pathway components.
p53/miR-34–dependent regulation of the 
Snail1 EMT program
In neoplastic states, the activation of cancer cell EMT programs 
by Snail1 triggers motile responses as well as tissue-invasive 
that the -catenin–LEF-1 axis regulates Snail1 stability via an 
Axin2-dependent process (Yook et al., 2006), the 3 UTR of 
Axin2 also contains miR-34–binding sites that directly con-
trol Axin2 levels (Fig. 6 D; Lee et al., 2009). Indeed, after ex-
pression of 3 UTR–deleted Axin2 in HCT116-p53
+/+ cells, 
the half-life of Snail1 protein is stabilized to levels observed 
in HCT116-p53
/ cells (Fig. 6 D). Hence, p53 inactivation 
and the resultant decrease in miR-34 expression affect Snail1 
Figure 3.  Induction of Snail1 expression by mutant p53. (A) MCF-7 cells were transfected with lentiviral vectors expressing wt p53, p53 mutant R175H, 
or p53 mutant R273H. Confocal images of E-cadherin levels in control MCF-7 cells and each of the transfected cell populations are shown. Bar, 20 µm. 
(B) p53, Snail1, and E-cadherin protein levels were determined in each transfected cell population by Western blot analysis. (C) Changes in Slug/Snail2 
expression in MCF-7 cells after transfection with mock, wt p53, R175H, or R273H mutant p53 lentiviral expression vectors as assessed by Western blot 
analysis. MDA-MB-231 cells were used as a positive control for Slug/Snail2 expression. (D) Snail1 expression in p53
fl/fl mouse fibroblast cells transduced 
with Ad-GFP or Ad-Cre as well as p53
/ MEFs after transduction with a control or p53 adenoviral expression vector. The Snail1 doublet represents the 
phosphorylated and nonphosphorylated forms, respectively.JCB • VOLUME 195 • NUMBER 3 • 2011   422
Figure 4.  Snail1 is a direct target of the miR-34 family. (A) Predicted interactions between miR-34a, -34b, and -34c, and Snail1 3 UTR sequences.   
Extended seed matches between the 5 end of miR-34 family (miR-34a, -34b*, and -34c-5p) and the 3 UTR binding sites of Snail1 (available from 
GenBank/EMBL/DDBJ under accession no. NM_005985) are shown. Binding energy was calculated by RNAhybrid. (B) Snail1 3 UTR reporter activity 
repression by miR-34 family expression vectors. The Snail1 3 UTR reporter construct cloned downstream of the firefly luciferase was transfected into A549 
or MCF-7 cells with control or miR-34 family expression vectors. Activity of the 3 UTR reporter construct was normalized to the activity of a cotransfected 423 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
Snail1  protein,  E-cadherin  promoter  activity  is  suppressed, 
and motility is induced in a Snail1 siRNA-sensitive fashion   
(Fig. 7, A–C). Conversely, when miR-34a is ectopically in-
troduced  into  HPV-E6–expressing  cells,  Snail1  3  UTR  re-
porter activity is inhibited, Snail1 protein levels decreases to 
baseline, and E-cadherin promoter activity returns to control 
levels as increases in Snail1-dependent motility are reversed 
machinery  (Yook  et  al.,  2005,  2006;  Peinado  et  al.,  2007;   
Ota et al., 2009; Thiery et al., 2009). As such, the ability of the 
p53–miR-34a axis to modulate Snail1-dependent cancer cell 
migration in A549 or MCF-7 cells, before or after transfec-
tion with an HPV-E6 expression vector, was assessed. In the 
presence of HPV-E6, Snail1 3 UTR reporter activity is up-
regulated in association with increased levels of endogenous 
SV-40 promoter renilla luciferase construct after a 2-d culture period. Results are expressed as the mean ± 1 SD for three or more experiments (error bars; 
*, P ≤ 0.01). (C) Schematic diagram depicting firefly luciferase reporter constructs containing the wt Snail1 3 UTR or deletion mutants of putative miR-34 
family interaction sites (top). Each of the 3 UTR reporter constructs was cotransfected with a synthetic control or miR-34a into MCF-7 cells, and normalized 
activity was assessed as described in A after a 2-d culture period. (*, P ≤ 0.01). (D) Immunoblot blot analysis of 293 cells transfected with FLAG-tagged 
human Snail1 expression vector without the Snail1 3 UTR (Snail-CDS) or an expression vector harboring the Snail1 3 UTR (nt +1 to +675; Snail-CDS   
3 UTR). The Snail1 expression vectors (300 ng each) were cotransfected with miR-34 family expression vectors (1 µg each) or anti–miR-34a oligonucleotides 
(40 pmol each). Whole-cell lysates were analyzed by immunoblotting with anti-FLAG monoclonal antibody after a 2-d culture period. Tubulin is shown 
as the loading control. (E) Transfection of A549 or MCF-7 cells with anti–miR-34a increased Snail1 3 UTR reporter activity after a 4-d culture period as 
described in A, with results presented as the mean ± 1 SD (n = 3; *, P ≤ 0.01). Immunoblot analyses of Snail1 and E-cadherin protein expression levels 
were performed in A549 or MCF-7 cells 4 d after transfection with control or anti–miR-34a (bottom). Tubulin is shown as the loading control.
 
Figure 5.  MDM2 inhibition represses Snail1 
expression.  (A)  Immunoblot  analysis  of  p53 
and Snail1 levels after treatment of A549 or 
MCF-7 cells with 10 µM nutlin-3a for 48 h.   
Tubulin  is  shown  as  the  loading  control.   
(B)  Quantitative  RT-PCR  analysis  of  miR-34a 
transcript levels after treatment with nutlin-3a. 
Results are expressed as the mean ± 1 SD of 
three experiments. (error bars; *, P ≤ 0.01). 
(C) 3 UTR activity of the Snail1 gene is re-
pressed by treatment with nutlin-3a for 48 h 
(red) compared with the DMSO control (blue) 
in A549 or MCF-7 cells. Results are expressed 
as the mean ± 1 SD of three experiments (error 
bars; *, P ≤ 0.01).JCB • VOLUME 195 • NUMBER 3 • 2011   424
Figure 6.  p53 and miR-34 regulate Snail1 protein stability. (A) Predicted target sites in Snail1 (NM_005985), -catenin (NM_001904), and LEF-1   
(NM_016269) by miR-34a, miR-34b*, and miR-34c-5p are indicated by the arrows. (B) miR-34 family members specifically repress -catenin 3 UTR or LEF-1 
3 UTR firefly luciferase reporter activity (normalized to the activity of a cotransfected SV-40 promoter renilla luciferase construct) after a 2-d culture period 
in A549 (left) or MCF-7 cells (right). Results are expressed as the mean ± 1 SD (error bars; n = 3; *, P ≤ 0.01). (C) 3 UTR activity of -catenin and LEF-1 
reporter constructs are regulated by p53 status in HCT116 cells. -catenin 3-UTR or LEF-1 3-UTR reporter constructs were transfected into HCT116-p53
+/+ 
or p53
/ cells alone or into HCT116-p53
/ cells in combination with a control adenoviral vector (p53
//Mock) or a p53-expressing adenoviral vector 425 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
(p53
//Ad-p53). After a 7-d culture period, reporter activities were normalized as described in A and presented as the mean ± 1 SD (error bars; n = 3;   
*, P ≤ 0.01). (D) Endogenous -catenin, LEF-1, and Axin2 protein levels were determined after a 4 d culture period by immunoblot analysis in HCT116-
p53
+/+ cells and HCT116-p53
/ cells transfected with control or miR-34a oligonucleotides. -actin is used as the loading control (insert). Snail1 protein 
half-life was determined in HCT116-p53
/ cells transfected with control or miR-34a oligonucleotides, or p53
/ cells transfected with miR-34a together with 
a mock or Axin2 expression vector after a 2-d culture period by quantifying residual levels of FLAG-tagged Snail1 (Snail1*) in cycloheximide-treated cells.
 
(Fig.  7,  A–C).  In  concert  with  the  observed  increases  in   
E-cadherin promoter activity induced by miR-34a, a similar 
up-regulation of the epithelial markers claudin-3 and occludin   
is  accompanied  by  decreases  in  fibronectin  and  vimentin 
expression (unpublished data). Although miR-34a can exert 
complex effects on cell cycle kinetics or apoptosis that might 
indirectly impact cancer cell migration (Bommer et al., 2007; 
Chang  et  al.,  2007;  Corney  et  al.,  2007;  He  et  al.,  2007a;   
Raver-Shapira et al., 2007; Tarasov et al., 2007), the motile   
response of miR-34a–expressing cells is rescued fully after 
Snail1 re-expression (Fig. 7 C). As expected, the increased   
migratory activity displayed by anti–miR-34a–transduced A549 
cells is lost after Snail1 silencing (Fig. 7 C).
Loss of p53 function has been associated with the acquisi-
tion of an aggressive, tissue-invasive phenotype (Gunther et al., 
2003; Lewis et al., 2005; Chen et al., 2007; Debies et al., 2008; 
Godar et al., 2008; Morton et al., 2008). During cancer cell 
EMT or EMT-like programs, neoplastic epithelial cells must 
first  perforate  the  underlying  basement  membrane  to  access 
underlying stromal tissues, a process that cannot be visualized 
readily in mouse models (Rowe and Weiss, 2008). Recently, 
however, a human-chick xenograft model has been developed 
where cancer cells can be cultured atop the chorioallantoic 
basement membrane of live animals to quantify invasive pro-
cesses (Ota et al., 2009). Under these conditions, fluorescently 
labeled p53-null HCT116 cells traverse basement membrane 
barriers (indicated by the broken lines in Fig. 7 D) and infil-
trate the underlying stromal tissues as assessed in H&E-stained 
tissue sections as well as by immunofluorescence (Fig. 7 D).   
After transfection with a miR-34a expression vector, invasion 
by p53-null HCT116 cells is inhibited by >80% as Snail1 pro-
tein  levels  fall  and  E-cadherin  expression  increases  (Fig.  7,   
E and F). The tissue-invasive potential of p53
/ HCT116 cells   
is similarly blocked when Snail1, but not Slug/Snail2, expres-
sion is silenced directly (Fig. S3), whereas the inhibitory effect 
exerted by miR-34a on invasion is reversed completely after 
transfection with a Snail1 expression vector (Fig. 7, D and F). 
These findings are not restricted to p53-null colon cancer cells 
alone, as the invasive phenotype displayed by MDA-MB-231 
cells, a breast carcinoma cell line that expresses mutant p53   
(Bykov et al., 2002), is similarly inhibited either by silenc-
ing Snail1 or after ectopic expression of miR-34a (Fig. 8 A). 
Likewise, Snail1 silencing or miR-34a expression each trigger   
the reexpression of epithelial cell markers in tandem with the down-
regulation of mesenchymal cell markers (Fig. 8 B). In contrast, 
decreasing endogenous miR-34a levels in wt MCF-7 by ex-
pressing mutant p53 not only increases Snail1 protein levels 
(Fig. 3), but induces a tissue-invasive response as well (Figs. 
S1 and S2). Together, these data support the proposition that 
decreases in miR-34 levels activate EMT programs wherein 
Snail1 serves as a dominant effector of the invasive phenotype.
Snail1 target gene expression signatures 
stratify miR-34a–deleted tumors
Based on the ability of the p53/miR-34 axis to induce a Snail1-
dependent EMT program in vitro, changes in miR-34 ex-
pression that occur as a consequence of p53 loss of function 
in vivo would be predicted to engage a Snail1-induced gene   
signature. However, efforts to link p53 status to Snail1 expres-
sion in vivo are complicated by at least two issues. First, p53 
loss of function or mutation alone does not necessarily associ-
ate with changes in miR-34 expression, as the microRNA is 
regulated by both p53-dependent and independent pathways 
(Bommer et al., 2007; Chang et al., 2007; Gallardo et al., 2009; 
Corney et al., 2010; Hermeking, 2010). Second, the complex 
posttranslational regulation of Snail1 protein levels precludes 
attempts to predict Snail1 activity as a function of its mRNA 
expression  levels  alone,  whereas  more  recent  studies  have   
demonstrated  that  Snail1  protein  phosphorylation,  whose   
status cannot be determined by immunohistochemistry, further 
regulates its transcriptional activity in a positive or negative 
fashion (MacPherson et al., 2010). As such, a publicly available   
patient cohort was interrogated containing neuroblastoma tumor   
samples  harvested  from  tissues  characterized  as  having  re-
tained, or deleted, chromosome 1p36, a region encoding miR-34a 
(Łastowska et al., 2007; Cole et al., 2008). Although neural 
crest-derived  in  origin,  neuroblastoma  tumors  also  undergo 
EMT-like changes when adopting an invasive or metastatic 
phenotype whose aggressive characteristics correlate with de-
creased miR-34a expression (Cole et al., 2008; Vitali et al., 
2008). Indeed, neuroblastoma tumor cell lines harboring 1p36 
deletions express only low levels of miR-34a while up-regulating 
Snail1, but not Slug, protein levels (Fig. 9, A and B). Using   
unsupervised hierarchical cluster analysis, the ability of a   
179-member Snail1 gene expression signature (derived from 
genes differentially expressed in wt vs. Snail1-deleted fibro-
blasts; Rowe et al., 2009) to stratify miR-34a–positive or 
–negative patient samples was determined. As shown in Fig. 9 C, 
the Snail1 signature correctly segregates patients based on the 
chromosomal loss of miR-34a with a high level of significance 
(P = 9.61483 × 10
6), which is consistent with a model wherein 
the p53-dependent as well as p53-independent regulation of 
miR-34 controls Snail1-mediated EMT programs.
Discussion
Snail1 expression has been linked to events ranging from the 
induction of carcinoma EMT-like programs and cancer recur-
rence to the generation of cancer stem cells (Moody et al., 2005; 
Olmeda et al., 2007; Mani et al., 2008; Kudo-Saito et al., 2009; 
Massoumi et al., 2009; Wu et al., 2009). Nevertheless, potential 
intersections between oncogenic processes, microRNA expres-
sion, and the regulation of Snail1 activity have not been defined JCB • VOLUME 195 • NUMBER 3 • 2011   426
Figure 7.  miR-34 blocks cell migration and EMT-associated invasion by silencing Snail1. (A) Immunoblot analysis and Snail1 3 UTR reporter activities 
48 h after transduction of an miR-34a expression vector into HPV-E6–expressing A549 or MCF-7 cells. Snail1 3 UTR reporter activity (normalized to a 
cotransfected XV-40 promoter renilla luciferase construct) was determined after HPV-E6 expression alone in A549 or MCF-7 cells, or alternatively, after co-
transfection with HPV-E6 in tandem with a control (control) or miR-34a (miR-34a) synthetic RNA oligonucleotide. Results are expressed as the mean ± 1 SD 
of three or more experiments (*, P ≤ 0.01). (B) Reporter activities of a wt E-cadherin promoter construct (blue) or its E-box mutant (red) were determined in 
HPV-E6–expressing A549 or MCF-7 cells 48 h after transfection with a control or miR-34a expression vector. E-cadherin promoter activity was determined 
as described in Fig. 2 E (mean ± 1 SD; n = 3; *, P ≤ 0.01). (C) The migratory activity of HPV-E6–expressing A549 cells relative to cells transfected with a 427 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
control vector (Mock) alone or cells transfected with HPV-E6 and either a Snail1 siRNA alone, miR-34a oligonucleotide alone, or miR-34a oligonucleotide 
and a Snail1 expression vector in tandem was determined after a 2-d culture period. Inhibition of endogenous miR-34a in wt A549 cells with a miR-34a 
antisense oligonucleotide (anti–miR-34a) increased cell migration after a 4-d culture period via a process reversed by Snail1 siRNA (anti–miR-34a/siSnail1) 
or a Snail1 shRNA (not depicted). Results are expressed as the mean ± 1 SD (n = 5; *, P ≤ 0.01). (D) HCT116-p53
/ cells were transfected with a control 
RNA oligonucleotide (control) alone, miR-34a oligonucleotide alone, or miR-34a in combination with mock (miR-34a/Mock) or Snail1 expression vectors 
(miR-34a/Snail1). After a 24-h culture period, the cells were labeled with fluorescent nanobeads and cultured atop the chorioallantoic membrane of live 
chick embryos for 3 d. Tissues were then removed, H&E-stained cross sections were prepared for light microscopy, or unstained frozen sections were 
examined by fluorescence microscopy. The boxed areas in the H&E-stained sections (the first and third rows in the panel) were magnified and examined 
by fluorescence microscopy to visualize directly the invasive activity of the green-colored cancer cells. The upper face of the chorioallantoic membrane is 
indicated by the broken lines in the fluorescent images. Bar, 50 µm. (E) HCT116-p53
/ cells were transfected with control or miR-34a oligonucleotides, 
and Snail1 or E-cadherin protein expression levels were monitored by immunoblot analysis after a 24-h culture period. (F) After transfection with an siRNA 
control (Scr) or one of two Snail1-specific siRNAs (si1Snail1 and si2Snail1), HCT116-p53
/ cells were cultured for 24 h in vitro before being inoculated 
on the chick chorioallantoic membrane. Relative invasion depth was monitored after a 3-d assay period as described in D. Alternatively, HCT116-p53
/ 
cells were transfected with control or miR-34a oligonucleotide alone, or with a miR-34a oligonucleotide in tandem with either a control expression vector 
(miR-34a/Mock) or a Snail1 expression vector (mi-R34a/Snail1), and cultured for 24 h in vitro before being placed atop the chorioallantoic membrane. 
Results are expressed as the mean ± 1 SD (error bars; n = 3; *, P ≤ 0.01).
 
previously. Herein, we demonstrate that p53, a potent yet fre-
quently mutated tumor suppressor, controls Snail1 activity via 
its ability to transactivate miR-34 family members. As such, 
modulation of Snail1 function is not only linked to alterations   
in p53 activity, but also to p53-independent changes in miR-34 
expression via gene deletion or epigenetic silencing (Hermeking, 
2010). Although loss of p53 or miR-34 function has been re-
ported to impact multiple targets that may lie outside of the 
Snail1 target range (e.g., Rho/Rock, c-Met, Notch, caldesmon, 
WISP-2, C-myc, and Id-2; Xia and Land, 2007; Gadea et al., 
2007; Dhar et al., 2008; Lujambio et al., 2008; Yan et al., 2008; 
Li  et  al.,  2009;  Mukhopadhyay  et  al.,  2009),  none  of  these   
accessory pathways are able to bypass an absolute require-
ment for Snail1 during the induction of tissue-invasive EMT 
activity in either p53- or miR-34–silenced cancer cells. Interest-
ingly, although mutant p53 has recently been proposed to act 
as a pro-invasive factor by virtue of its ability to suppress p63 
function in a cell context–dependent fashion (Adorno et al., 
2009; Muller et al., 2009), Snail1 directly represses the expres-
sion  of  Np63,  the  dominant  p63  isoform  responsible  for 
maintaining the epithelial phenotype (Higashikawa et al., 2007; 
Koster et al., 2007). Indeed, in our hands, cancer cells that do 
not express mutant p53 (i.e., HCT116-p53
/ colon carcinoma 
cells as well as HPV-E6–treated MCF-7 or A549 cells) undergo 
Snail1-dependent  EMT  and  display  tissue-invasive  activity   
after either the loss of wt p53 function or the silencing of   
endogenous miR-34. These findings do not, however, preclude 
the ability of p53 mutants to confer expressing cells with addi-
tional  gain-of-function  activities  that  complement  Snail1- 
dependent activities (Adorno et al., 2009; Muller et al., 2009). 
Nevertheless, given the ability of Snail1 to directly regulate 
EMT programs in multiple neoplastic cell populations (Peinado 
et al., 2007; Debies et al., 2008; Thiery et al., 2009; Vincent   
et al., 2009; Wu et al., 2009), the identification of this transcrip-
tional repressor as a downstream effector of a dysfunctional 
p53–miR-34 network unveils a potentially important axis in   
tumor progression. Caution should, however, be exercised in 
assuming that Snail1 activity is linked solely to EMT-associated, 
pro-invasive events. Snail1 can also impact cell cycle activity 
and apoptotic pathways, key targets for both p53 and miR-34 
(Barrallo-Gimeno and Nieto, 2005; Hermeking, 2010). In our 
hands, however, Snail1 directly induces EMT as well as invasive 
activity independently of any effects on tumor cell proliferation 
or apoptosis (Ota et al., 2009). Instead, Snail1 operates as a crit-
ical regulator of motile activity in combination with the activa-
tion of membrane-type matrix metalloproteinases that play 
necessary roles in conferring cancer cells with tissue-invasive 
activity during EMT (Ota et al., 2009; Rowe and Weiss, 2009). 
Given the fact that Snail1 has been detected within the invasive 
front of human breast, colon, and prostate carcinomas (Francí   
et al., 2009; Vincent et al., 2009; Wu et al., 2009; Mak et al., 
2010), our data lend further support to models of invasion 
wherein the reversible and local activation of EMT or EMT-like 
programs promote cancer cell invasion (Polyak and Weinberg, 
2009; Thiery et al., 2009).
Independent of the ability of the p53/miR-34 axis to regu-
late Snail1 activity and function, p53 has also been reported to 
regulate Slug/Snail2 (and, more recently, Snail1 protein levels) 
via a novel process involving the MDM2-dependent degrada-
tion of these transcriptional repressors (Wang et al., 2009; Lim 
et al., 2010). In our studies, however, neither loss of p53 expres-
sion nor expression of mutant p53 induced Slug/Snail2 expres-
sion. Further, silencing Slug/Snail2 expression in HCT116 cells 
failed to affect invasive activity. In addition, the MDM2 in-
hibitor, nutlin-3a, which has been reported to stabilize Snail1/2 
levels by preventing their ubiquitination and subsequent protea-
somal destruction (Wang et al., 2009; Lim et al., 2010), instead 
decreases Snail1 protein levels by increasing miR-34a levels 
as a consequence of stabilizing p53. Though p53 may never-
theless regulate Slug/Snail2 by divergent, miR-34–independent 
mechanisms under select circumstances, our studies reinforce 
accumulating evidence that Snail1 plays a dominant role in 
regulating EMT-associated cancer invasion programs under 
conditions in which the transcription factors are coexpressed 
(Olmeda et al., 2008). Interestingly, although our work was   
under review, Chang et al. (2011) likewise reported that p53   
can regulate EMT, but via a distinct mechanism linked to   
miR-200c and Zeb1 expression. These studies were largely con-
fined to analyses of normal epithelial cell lines, and the impact of 
Zeb1 silencing on p53-induced EMT was not assessed (Chang 
et al., 2011). However, as Snail1 can also regulate miR-200c 
(Burk et al., 2008; Gill et al., 2011), it seems likely that p53 con-
trols EMT through multiple miRNA-dependent routes. Never-
theless, we were unable to detect changes in Zeb1 expression JCB • VOLUME 195 • NUMBER 3 • 2011   428
altered in combination with microenvironmental changes known 
to  support  Snail1  mRNA  expression,  including  increases  in 
TGF, TNF, HGF, EGF, FGF, or hypoxia-inducible factor 
signaling (Peinado et al., 2007; Sahlgren et al., 2008; Yang   
et al., 2008; Vincent et al., 2009; Wu et al., 2009; Mak et al., 
2010). Likewise, p53 loss-of-function or mutation occur frequently 
as a later event in cancer progression (Vogelstein et al., 2000), 
which suggests that the acquisition of invasive activity occurs 
in conjunction with additional oncogenic events, particularly 
in p53 wt versus p53-null cancer cells (Fig. S1), and our data 
demonstrate clearly that silencing Snail1 or expressing miR-34 
in p53-null cells is sufficient to reverse EMT programs in mul-
tiple cell populations.
Although alterations in p53 or miR-34 status directly im-
pact on Snail1 activity and function, we find that neither of these 
regulatory axes affects Snail1 transcription directly. Hence, the 
induction of Snail1-mediated EMT programs falls under the 
control of binary events wherein p53 or miR-34 function is 
Figure 8.  Snail1- and miR-34-dependent invasion program of MDA-MB-231 cells. (A) MDA-MB-231 cells were transfected with control siRNA (Scr), 
Snail1-specific siRNA (siSnail1), a control RNA oligonucleotide (control), or a miR-34a RNA oligonucleotide, and after a 24-h culture period in vitro, 
labeled with fluorescent nanobeads, and cultured atop the live chick chorioallantoic membrane for 3 d. Frozen sections were examined by fluorescence 
microscopy with labeled MDA-MB-231 cells colored green. The upper face of the chorioallantoic membrane is indicated by broken lines. Relative invasion 
depth was monitored after a 3-d assay period (n = 3; *, P ≤ 0.01). Error bars indicate mean ± 1 SD. Bar, 50 µm. (B) Snail1, E-cadherin, claudin 3, 
occludin, fibronectin, and vimentin mRNA transcript levels in MDA-MB-231 cells after transfection with control or Snail1 siRNAs, or control versus an 
miR-34a RNA oligonucleotide were determined by RT-PCR. Endogenous Snail1 protein levels were also assessed by immunoblot analysis after transfection 
with control () or miR-34a oligonucleotides (+) in MDA-MB-231 cells. Tubulin serves as the loading control. E-cadherin, claudin-3, occludin, fibronectin, 
and vimentin mRNA levels were determined in control or miR-34a–treated MDA-MB-231 cells by RT-PCR.429 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
Figure 9.  Cluster analysis of neuroblastoma clinical cohort. (A) miR-34a expression levels in 1p36-positive and 1p36-deleted human neuroblastoma 
cells. (B) Snail1 and Slug/Snail2 protein levels in 1p36-positive and 1p36-deleted neuroblastoma cells as determined by Western blot analysis. Cell lines 
expressing recombinant Snail1 or recombinant Slug/Snail2 were used as positive controls. (C) Heat map shows average-linkage hierarchical clustering, 
using a Euclidean distance metric, performed on 23 neuroblastoma patient samples. Clinical samples harboring a deletion of chromosome 1p are indicated 
with a red bar. Two distinct clusters, A and B, are highlighted in the gray boxes.JCB • VOLUME 195 • NUMBER 3 • 2011   430
with activating mutations in Ras and/or the PI3 kinase axis 
(Lewis et al., 2005; Xia and Land, 2007; Morton et al., 2008). 
Our  experimental  conditions  did  not  require  the  addition  of   
exogenous growth factors or cytokines to activate Snail1- 
dependent EMT programs after loss of wt p53 function or miR-34 
silencing, but we have reported previously that serum alone is   
a potent stimulus of Snail1 transcription (Rowe et al., 2009). 
Given the fact that conditions permissive for Snail1 transcrip-
tion and activation operate within a range of neoplastic states 
(Rowe and Weiss, 2009), we sought to extend our findings into 
the clinical setting where correlations between p53 status, miR-34 
levels, Snail1 expression, and disease progression might be 
uncovered. However, several caveats complicated these efforts. 
First, in human tumor tissues, p53 mutations do not correlate 
strictly with miR-34 levels (Bommer et al., 2007; Chang et al., 
2007; Gallardo et al., 2009; Corney et al., 2010). For example, 
miR-34 silencing via promoter methylation is more frequently 
increased in p53 wt, as opposed to p53 mutant, tumor samples 
(Corney et al., 2010; Hermeking, 2010). Second, although the 
complex posttranslational regulation of Snail1 protein levels 
precludes attempts to predict Snail1 activity as a function of its 
mRNA expression levels alone, few, if any, commercial anti-
bodies have undergone the rigorous testing needed to validate 
their use in the clinical arena (Becker et al., 2007). This issue 
notwithstanding, more recent studies indicate that the Snail1 
protein can reside within the nuclear compartment in either   
active or inactive states dependent on its phosphorylation status,   
a functional change that cannot be resolved by immunohisto-
chemistry alone (MacPherson et al., 2010).
As an alternative approach, we reasoned that an unequivo-
cal decrease in miR-34a expression, an event precipitated by 
the deletion of chromosome region 1p36 in multiple cancer 
types (Yamakuchi et al., 2008), could result in the induction of 
a Snail1 gene signature. A search of public databases indicated 
that a large cohort of neuroblastoma tissues, a pediatric tumor 
type wherein miR-34a has been identified as a candidate tumor 
suppressor gene on the basis of frequent 1p36 deletions (Welch 
et al., 2007; Cole et al., 2008), had previously undergone ex-
pression profiling as a function of their chromosome 1p status 
(i.e., either 1p-positive or negative; Łastowska et al., 2007). 
Using a Snail1 gene expression signature derived from earlier 
profiling studies performed in our laboratory comparing Snail1-
floxed to Snail1-deleted cells (Rowe et al., 2009), all 11 of 
the chromosome 1p–negative/miR-34a–deleted neuroblastoma 
patients were identified correctly, with only one false positive 
recorded at a high level of statistical significance. Though we 
cannot rule out the possibility that additional tumor regulatory 
molecules lie encoded within the chromosome 1p36 region, no 
other conventional tumor suppressor genes have been identified 
in this region (Cole et al., 2008; Yamakuchi et al., 2008). As 
such, analysis of this patient cohort provides additional support 
for our contention that p53-dependent or independent regula-
tion of miR-34 expression can impact Snail1-initiated transcrip-
tional programs in vivo (Fig. 10), as well as a range of upstream 
Wnt targets (Kim et al., 2011). Although further studies are 
required to define in comprehensive fashion those p53 mutant 
phenotypes that are mediated by changes in miR-34 expression, 
the studies outlined herein clearly identify Snail1 as a key, and 
as of yet unsuspected, downstream effector of the dysregulated 
p53 axis in cancer.
Materials and methods
Cells and cell assays
HCT116 p53
+/+ and isogenic HCT116 p53
/ cell lines (provided by   
B. Vogelstein, Johns Hopkins University, Baltimore, MD); p53
/ mouse 
embryonic  fibroblasts  (MEFs);  MCF-7,  A549,  MDA-MB-231,  and  293 
cells; and neuroblastoma cell lines (all from the American Type Culture Col-
lection) were cultured as described previously (Yook et al., 2005, 2006). 
The predicted miR-34 family target sites in the 3 UTR of Snail1, -catenin, 
and LEF-1 were identified as described previously (Lee et al., 2009). siRNA 
duplexes or small hairpin RNA (shRNA) expression vectors for Snail1 or 
p53 silencing as well as scrambled controls have been described previ-
ously (Yook et al., 2005, 2006; Bommer et al., 2007). siRNA duplexes 
directed against human p53 as well as scrambled controls were obtained 
from Santa Cruz Biotechnology, Inc. Adenoviral expression vectors for 
GFP (Ad-GFP, #1060) and GFP-p53 (Ad-GFP-p53, #1260) were obtained 
from Vector Biolabs. For migration assays, A549 or HPV-E6–transfected 
A549 cells were transfected with control siRNA, Snail1 siRNA, miR-34a, or 
anti-miR-34a with Lipofectamine. After 24 h, cells were trypsinized, 10
5 cells 
were seeded into Transwell inserts (3.0 µm pore; BD), and the number of 
cells migrating to the basal side of the membrane insert was determined 
at 18 h. Cancer cell invasion into the live chorioallantoic membrane of 
11-d-old chick embryos was performed as described previously (Ota et al., 
2009). Invasion was quantified after a 3-d culture period in cross sections 
of the fixed chorioallantoic membrane by fluorescent microscopy (DM-LB; 
Leica) using either a 10× or 20× objective lens, 0.50 numerical aperture 
(Leica). Phase contrast and chick chorioallantoic membrane images were 
acquired and analyzed with a SPOT camera and software (Diagnostic 
Instruments, Inc.; Ota et al., 2009).
Confocal microscopy and immunoblot analysis
Confocal imaging and Western blotting were performed as described pre-
viously (Yook et al., 2005) with antibodies directed against E-cadherin   
(Invitrogen), -catenin (BD), LEF-1 (Abcam), Snail1 (Cell Signaling Technol-
ogy), Snail2/Slug (Cell Signaling Technology), Axin2 (Cell Signaling Tech-
nology), tubulin (Labfrontier Co., Ltd.), p53 (Santa Cruz Biotechnology, 
Inc.), or FLAG-tagged proteins (Sigma-Aldrich). Confocal images of cells 
were acquired on a confocal microscope (FV500) using a 60× or 100× 
water immersion lens, 1.20 numerical aperture, using FluoView software 
(all from Olympus). Control and test images for each experimental set were 
acquired with equal photomultiplier tube intensity and gain settings.
Expression and reporter constructs
An HPV-16 E6 open reading frame (provided by K.H. Kim, Yonsei University, 
South Korea; Kim et al., 1995) and retroviral expression vector of HPV-E6 
were constructed by cloning HPV-E6 into pQCXIP retroviral expression 
Figure 10.  Schematic cartoon outlining the regulation of Snail1 activity 
by the p53/miR-34 axis.431 p53 transactivation of miR-34 regulates Snail1 • Kim et al.
Snail1 signature. Publicly available primary neuroblastoma cancer profiling 
data (GSE13141; Łastowska et al., 2007), using the HG-U133A Plus 2.0 
array  platform,  were  downloaded  from  the  Gene  Expression  Omnibus 
(http://www.ncbi.nlm.nih.gov/geo/).  To  ensure  that  profiling  was  lim-
ited to the effects exerted by miR-34a, seven samples harboring potential 
losses in miR-34b/c expression because of chromosome 11q deletions   
were removed from the sample set. Unsupervised hierarchical cluster analy-
sis  was  conducted  using  TIGR  Multi  Experiment  Viewer  (Saeed  et  al., 
2006). Genes were log transformed and mean centered before performing   
average-linkage hierarchical clustering, with a Euclidean distance metric, 
on both samples and genes. Using the R statistical package, a two-tailed 
Fisher’s  exact  test  was  performed  to  assess  the  statistical  significance   
between the hierarchical clusters and 1p deletion.
Online supplemental material
Fig. S1 shows p53-dependent regulation of Snail1, Snail2, Zeb1, and 
Twist1 expression; and EMT. Fig. S2 shows p53-dependent control of 
miR-34 expression. Fig. S3 shows Snail1- and Snail2-dependent regulation 
of EMT. Table S1 shows miR-34 and Snail1 3 UTR sequence conservation. 
Online  supplemental  material  is  available  at  http://www.jcb.org/cgi/ 
content/full/jcb.201103097/DC1.
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